glucosamine has been researched along with Diabetes Mellitus, Type 1 in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (55.56) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Dizon, BLP; Greenspan, NS; Kearney, JF; King, RG; New, JS | 1 |
| Benedek, G; Gyarmati, P; Halmos, KC; Jancsó, G; Maimaiti, S; Smith, BN; Xu, H | 1 |
| Bronstein, JA; Crandon, SK; Hall, G; Hortin, GL; Karne, RJ; Muniyappa, R; Quon, MJ; Ver, MR | 1 |
| Albert, SG; Haas, MJ; McPherson, T; Mooradian, AD; Oiknine, RF; Parseghian, S | 1 |
| Tattersall, R | 1 |
| Burcharth, F; Deckert, M; Deckert, T; Horowitz, IM; Kjellén, L; Kofoed-Enevoldsen, A; Lykkelund, C | 1 |
| Alexopoulos, E; Dimitriadis, G; Ganotakis, M; Hatziagellaki, E; Komesidou, V; Kordonouri, O; Raptis, S | 1 |
| Berzin, M; Diamond, TH; Griffiths, RF; Kalk, WJ; Osler, CE; Smit, AM; Wing, J | 1 |
| Humphries, DE; Palmer, ME; Silbert, CK; Silbert, JE | 1 |
| Gray, RS; Hillman, RJ; Scott, M | 1 |
| Dimitriadis, G; Hatziagelaki, E; Hillebrand, I; Ladas, S; Linos, A; Raptis, S | 1 |
| Cañizo, JF; Hillebrand, I; Navascués, I; Sabán, J; Serrano-Rios, M | 1 |
| Gerich, JE; Kennedy, FP | 2 |
| Dimitriadis, G; Halvatsiotis, P; Hatziagelaki, E; Hillebrand, I; Ladas, S; Mitrakou, A; Raptis, A; Raptis, S | 1 |
| Bachmann, W; Hillebrand, I; Lotz, N; Rinninger, F | 1 |
| Jacker, HJ | 1 |
| Ahola, T; Akerblom, H; Hiekkala, H | 1 |
2 review(s) available for glucosamine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Blood Glucose; Diabetes Mellitus, Type 1; Eating; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Imino Pyranoses; Trisaccharides | 1993 |
[Antidiabetics. 42].
Topics: Adolescent; Adult; Aged; Biguanides; Carbutamide; Child; Child, Preschool; Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucosamine; Humans; Hypoglycemic Agents; Infant; Insulin; Insulin, Long-Acting; Middle Aged; Oxazoles; Plants, Medicinal; Pyrazoles; Quinolines; Sulfadiazine; Sulfathiazoles; Tolbutamide; Triazines; Urea | 1969 |
9 trial(s) available for glucosamine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects.
Topics: Administration, Oral; Adult; Ascorbic Acid; Blood Pressure; Diabetes Mellitus, Type 1; Endothelium, Vascular; Glucosamine; Heart Rate; Humans; Insulin Resistance; Obesity; Reference Values; Thinness | 2006 |
The effect of glucosamine on Serum HDL cholesterol and apolipoprotein AI levels in people with diabetes.
Topics: Aged; Apolipoprotein A-I; Blood Glucose; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Glucosamine; Humans; Hypolipidemic Agents; Male; Middle Aged | 2007 |
The acute effects of glucosidase inhibition on post-meal glucose increments in insulin-dependent diabetics.
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Middle Aged; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Effect of alpha-glucosidase inhibition on glucose profiles in insulin dependent diabetes.
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 1; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Middle Aged; Triglycerides | 1989 |
Effects of prolonged administration of two new alpha-glucosidase inhibitors on blood glucose control, insulin requirements and breath hydrogen excretion in patients with insulin-dependent diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Anti-Bacterial Agents; Blood Glucose; Breath Tests; Diabetes Mellitus, Type 1; Drug Administration Schedule; Glucosamine; Humans; Hydrogen; Imino Pyranoses; Insulin; Male | 1988 |
Effect of two new alpha-glucosidase inhibitors in insulin-dependent diabetic patients.
Topics: 1-Deoxynojirimycin; Adult; Diabetes Mellitus, Type 1; Diet; Double-Blind Method; Female; Glucosamine; Glucosidases; Humans; Hyperglycemia; Hypoglycemia; Imino Pyranoses; Insulin; Male; Random Allocation | 1988 |
A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitus.
Topics: 1-Deoxynojirimycin; Anti-Bacterial Agents; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Dietary Carbohydrates; Eating; Female; Glucosamine; Humans; Imino Pyranoses; Insulin; Male; Random Allocation | 1987 |
Effects of two new alpha-glucosidase inhibitors on glycemic control in patients with insulin-dependent diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Breath Tests; Clinical Trials as Topic; Deuterium; Diabetes Mellitus, Type 1; Double-Blind Method; Glucosamine; Humans; Imino Pyranoses; Insulin; Insulin Infusion Systems; Male; Random Allocation | 1986 |
[Miglitol in the treatment of the insulin-dependent diabetic patient. Improved metabolic control and excellent tolerance].
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Glucosamine; Glycated Hemoglobin; Humans; Imino Pyranoses | 1987 |
7 other study(ies) available for glucosamine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
B-1 B Cell-Derived Natural Antibodies against N-Acetyl-d-Glucosamine Suppress Autoimmune Diabetes Pathogenesis.
Topics: Acetylglucosamine; Animals; Diabetes Mellitus, Type 1; Glucosamine; Mice; Mice, Inbred NOD; Pancreas | 2023 |
Molecular and functional changes in glucokinase expression in the brainstem dorsal vagal complex in a murine model of type 1 diabetes.
Topics: Action Potentials; Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; GABAergic Neurons; Glucokinase; Glucosamine; Glucose; KATP Channels; Male; Mice; Mice, Transgenic; Solitary Nucleus; Streptozocin; Synaptic Potentials | 2015 |
Possible genetic defects in regulation of glycosaminoglycans in patients with diabetic nephropathy.
Topics: Adult; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fibroblasts; Glucosamine; Glycosaminoglycans; Humans; Kinetics; Male; Reference Values; Skin; Sulfates; Sulfur Radioisotopes; Tritium | 1991 |
Effects of alpha-glucosidase inhibition on meal glucose tolerance and timing of insulin administration in patients with type I diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Eating; Energy Intake; Glucosamine; Glucose Clamp Technique; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male | 1991 |
Production of [3H]hexosamine-labeled proteoglycans by cultures of normal and diabetic skin fibroblasts: dilution of exogenous [3H]glucosamine by endogenous hexosamine from glucose and other sources.
Topics: Adult; Cells, Cultured; Diabetes Mellitus, Type 1; Female; Fibroblasts; Glucosamine; Humans; Kinetics; Male; Middle Aged; Proteoglycans; Radioisotope Dilution Technique; Reference Values; Skin; Sulfates; Sulfur Radioisotopes; Tritium | 1989 |
Alpha-glucosidase inhibition and timing of preprandial insulin in patients with insulin-dependent diabetes mellitus (IDDM).
Topics: 1-Deoxynojirimycin; Blood Glucose; Diabetes Mellitus, Type 1; Drug Administration Schedule; Eating; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Kinetics; Male | 1988 |
Some aspects on plasma lipid and protein fractions in juvenile diabetics.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Diabetes Mellitus, Type 1; Female; Glucosamine; Glycerides; Humans; Insulin; Lipids; Male; Mucoproteins; Phospholipids; Triglycerides | 1966 |